The RNA m6A writer WTAP in diseases: structure, roles, and mechanisms
2022 · Cell Death and Disease · 128 citations
https://doi.org/10.1038/s41419-022-05268-9
J
Jie Mo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
717
Citations
12
h-index
13
i10-index
Jie Mo is an academic researcher from Guangxi Medical University. The author has contributed to research in topics: Ubiquitin and proteasome pathways & Acupuncture Treatment Research Studies & Cancer, Hypoxia, and Metabolism. The author has an h-index of 12, co-authored 30 publications.
Papers by this author
worksThe role of YAP1 in liver cancer stem cells: proven and potential mechanisms
2022 · Biomarker Research · 19 citations
https://doi.org/10.1186/s40364-022-00387-z
Disrupting CCDC137-mediated LZTS2 and β-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via β-catenin and AKT
2024 · Cell Death and Differentiation · 9 citations
https://doi.org/10.1038/s41418-024-01328-z
CKAP4 in hepatocellular carcinoma: competitive RETREG1/FAM134B binding, reticulophagy regulation, and cancer progression
2024 · Autophagy · 8 citations
https://doi.org/10.1080/15548627.2024.2435236
Long noncoding RNA HOXC-AS3 interacts with CDK2 to promote proliferation in hepatocellular carcinoma
2022 · Biomarker Research · 7 citations
https://doi.org/10.1186/s40364-022-00411-2
Targeting FAM134B-DDX3X axis inhibiting AKT signaling in hepatocellular carcinoma
2025 · Cell Death and Disease · 1 citations
https://doi.org/10.1038/s41419-025-08080-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat